Sourasky Medical Center (Ichilov)
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.
Treatment options in Israel utilize a multidisciplinary approach combining surgical excision, sclerotherapy, and medical management. Leading centers provide specialized pediatric care. They offer minimally invasive laser therapy and advanced drug protocols for complex or inoperable cases. Facilities like Hadassah and Sourasky maintain high success rates.
Bookimed Expert Insight: Israeli medical centers demonstrate a significant scale advantage for pediatric cases. Hadassah and Sourasky together treat over 22,000 children annually. This high volume allows surgeons to maintain specialized skills in rare vascular malformations. Our data shows oncology success rates reaching 90% at Sourasky. This expertise often translates to more precise management of complex lymphangioma cases.
Patient Consensus: Parents emphasize that early sclerotherapy often prevents more invasive surgeries later. Patients note that while recurrence is possible, combining systemic medications like Sirolimus with local treatments provides the best long-term stability.
Israel treats lymphangioma at tertiary centers like Sourasky Medical Center and Hadassah Medical Center. Specialized departments utilize multidisciplinary teams for vascular malformations. These facilities hold Joint Commission International (JCI) accreditation. They offer advanced sclerotherapy, laser therapy, and minimally invasive surgeries for pediatric and adult cases.
Bookimed Expert Insight: Lymphangioma cases in Israel often benefit from specialized pediatric infrastructure. Data shows Hadassah and Sourasky manage high volumes, with Sourasky treating 11,000+ children yearly. These centers frequently use non-surgical methods like sclerotherapy. This approach can resolve 80% of cases without requiring hospitalization stay.
Patient Consensus: Patients emphasize finding specialists specifically in vascular anomalies rather than general surgery. Many note that starting with medical therapies like sirolimus often yields better results than immediate surgery.
Top specialists for lymphangioma in Israel operate within major multidisciplinary centers like Sourasky Medical Center and Hadassah Medical Center. These experts include pediatric surgeons and interventional radiologists. Many are recognized by Newsweek and Forbes for excellence in rare pediatric and oncologic conditions.
Bookimed Expert Insight: Israeli medical centers often function as university hospitals where specialists share research. For instance, Hadassah is a multi-specialty university facility. This academic structure ensures that even rare cases like lymphangioma benefit from a team-based review rather than a single doctor’s opinion. When choosing, look for clinics with over 75 specialized departments to ensure full support.
Patient Consensus: Patients note that finding an experienced specialist is difficult due to the condition's rarity. They emphasize that success depends on a team including interventional radiologists and pediatric surgeons.
Israel reports high success rates for pediatric vascular malformations like lymphangioma at specialized centers. General surgical procedures maintain a 95% success rate in accredited facilities. Precision diagnosis and multidisciplinary teams at academic hospitals ensure optimal outcomes for complex cystic lesions.
Bookimed Expert Insight: Israeli hospitals often combine private patient choice with university-level research expertise. Assuta allows patients to select their specific surgeon. Meanwhile, Hadassah uses Nobel Prize-recognized research to manage rare pediatric conditions. This dual approach ensures high-level surgical skill and advanced diagnostic accuracy.
Patient Consensus: Parents emphasize that location and size determine success more than raw numbers. Many prioritize finding surgeons with experience in 85%+ success rates for macrocystic cases to avoid regrowth.
Pediatric lymphangioma treatment in Israel prioritizes minimally invasive techniques over aggressive surgery. Specialized centers focus on preserving developing tissues and managing growth patterns. Doctors often utilize sclerotherapy or medication trials like sirolimus as first-line interventions for children. These approaches minimize scarring and reduce surgical risks.
Bookimed Expert Insight: While adult lymphangioma treatment often leans toward surgical removal, Israeli pediatric specialists frequently implement staged treatments. Data from high-volume centers like Sourasky Medical Center shows they manage over 11,000 pediatric cases yearly. This volume allows surgeons to accurately predict which lesions require early intervention to prevent airway issues and which can wait. Choosing a center with a dedicated pediatric department ensures access to multidisciplinary teams familiar with these specific growth factors.
Patient Consensus: Parents note that Israeli specialists often suggest starting with less invasive options like sclerotherapy first. They emphasize the importance of monitoring for potential recurrence, which can be higher in children under 5.
During your first consultation for lymphangioma in Israel, ask about the surgeon's personal case volume and success rates. Inquire whether they recommend surgical resection, sclerotherapy, or medical management like Sirolimus. Ensure you discuss recurrence risks and the precise post-operative monitoring timeline for international patients.
Bookimed Expert Insight: Israeli medical centers like Hadassah and Sourasky handle massive patient volumes, with some facilities seeing over 1,000,000 people yearly. This high throughput often means surgeons specialize in rare conditions like lymphangioma more frequently than in smaller regional hospitals. When consulting with experts like Dr. Yuri Goldes, focus on their experience with minimally invasive techniques that may reduce your recovery time.
Patient Consensus: Patients emphasize the need to push for specific complication risks, such as nerve damage or lymphedema. Many recommend recording the session to catch important details often lost in complex medical jargon.